Device to Assist With Abdominal Access During Laparoscopic Surgery
Pilot Study to Establish Safety and Ease of Use of a TauTona Pneumoperitoneum Assist Device (TPAD) for Laparoscopic Surgery
1 other identifier
interventional
31
1 country
1
Brief Summary
The purpose of this study is to assess the safety and ease of use of a TauTona Pneumoperitoneum Assist Device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for placing a primary trocar, during laparoscopic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedStudy Start
First participant enrolled
June 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2024
CompletedResults Posted
Study results publicly available
July 1, 2025
CompletedJuly 1, 2025
June 1, 2025
2 years
May 13, 2020
June 11, 2025
June 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Surgeon Satisfaction Survey
The surgeon completes a LIKERT scale satisfaction survey related to the TPAD to assess its ease of use. Scale range 1-5 (higher scores correspond to higher satisfaction)
up to 1 minute on day of surgery
Secondary Outcomes (2)
Time From Incision for Veress Needle Insertion to Start of Insufflation
Up to approximately 2 minutes
Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0
Continuous from start of surgery through postoperative day 7
Study Arms (2)
TauTona Pneumoperitoneum Assist Device (TPAD)
EXPERIMENTALParticipants will receive investigational TPAD device during laparoscopic surgery. The TPAD was used to aid Veress needle insertion in place of surgical tools such as clamps. The TPAD was applied to the patient prior to Veress needle entry and removed after insufflation was completed.
Standard of Care (SOC)
ACTIVE COMPARATORParticipants will receive SOC included both direct (unassisted) entry and assisted entry using clamps, if needed, to aid in Veress needle insertion. Upon confirmation that the Veress needle was in the correct location (e.g. drop test), insufflation was initiated.
Interventions
The TPAD is an experimental device used to assist with placement of Veress needle during laparoscopic surgery.
Standard of Care was used for Veress needle insertion.
Eligibility Criteria
You may qualify if:
- Age \>/= 18
- Scheduled for laparoscopic surgery
- Able to understand and willing to sign a written informed consent form
You may not qualify if:
- Age \< 18
- Any situation where blind, peri-umbilical passage of a Veress needle is contraindicated.
- Any situation where patients have suspected or confirmed intra-abdominal adhesions involving the peri-umbilical abdominal wall.
- Any situation where patients have a suspected or confirmed umbilical hernia or peri-umbilical ventral hernia.
- Any situation where there is not intact, uncompromised skin of the peri-umbilical region where the device is to be placed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- TauTona Groupcollaborator
Study Sites (1)
Stanford University
Stanford, California, 94304, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Study Team
- Organization
- Stanford University
Study Officials
- PRINCIPAL INVESTIGATOR
James R Korndorffer Jr, MD MHPE FACS
Stanford University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2020
First Posted
May 19, 2020
Study Start
June 20, 2022
Primary Completion
June 17, 2024
Study Completion
June 17, 2024
Last Updated
July 1, 2025
Results First Posted
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share